Skip to main content
Wolfson Institute of Population Health

Dr Rachel Phillips

Rachel

Senior Lecturer in Medical Statistics

Email: Rachel.phillips@qmul.ac.uk

Profile

I am a Senior Lecturer in Medical Statistics in the Centre for Evaluation based in the Pragmatic Clinical Trials Unit. I have worked in the area of clinical trials for over 10 years and I have a broad range of experience in the design and analysis of clinical trials. I am also the module lead for the Effective and Efficient Evaluation module of the MRes in Health Data in Practice.

My methodological research interests focus on the reporting and analysis of adverse events in clinical trials and the development of statistical methods to better identify adverse reactions. I am recognised both nationally and internationally for my work in this area and have recently established a harms theme for the MRC-NIHR Trials Methodology Research Partnership Outcomes Working Group, which I co-lead.

I obtained a BSc in Mathematics from the University of Nottingham in 2008 and was awarded an NIHR Research Methods Fellowship to complete my MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine in 2009, after which I spent two years working as a statistician at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. In 2012 I moved to Singapore to work for an academic clinical research organisation focusing on clinical trials in infectious diseases and mental health. I joined the Division of Health and Social Care Research, King’s College London in 2015 as a research fellow to work as a clinical trial statistician including both early and later phase trials. During this time I also worked as a general adviser for the NIHR Research Design Service. I was awarded an NIHR Doctoral Research Fellowship in 2018 to undertake my PhD at Imperial College London, which I completed in 2021.

Research

Research Interests:

My methodological research interests focus on the reporting and analysis of adverse events in clinical trials and the development of statistical methods to better identify adverse reactions. I am recognised both nationally and internationally for my work in this area and have recently established a harms theme for the MRC-NIHR Trials Methodology Research Partnership Outcomes Working Group, which I co-lead.

Back to top